https://frontierpicks.com/portfolio/ Every change the FrontierPicks portfolio makes, with the dated fact behind it, its weekly letters, and every rating change on the stocks it holds. en Fri, 13 Nov 2026 12:00:00 GMT https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-13-LLY-add Fri, 13 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:add ticker:LLY Added to LLY on company news. The fact behind it, dated 12 November 2026: China's National Medical Products Administration approved Foundayo (orforglipron) for weight management, the first oral GLP-1 weight-loss drug cleared in China, reported 12 November 2026. https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-13-IMAX-buy Fri, 13 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:buy ticker:IMAX Bought IMAX on results. The fact behind it, dated 5 November 2026: Q3 2026 results: revenue rose 64% to $174.6 million, adjusted EBITDA was $120.9 million at a 69.3% margin, and the 2026 adjusted EBITDA margin target was raised to about 50% from the mid-40s. https://frontierpicks.com/portfolio/letters/2026-11-13/ https://frontierpicks.com/portfolio/letters/2026-11-13/ Fri, 13 Nov 2026 21:45:00 GMT FrontierPicks portfolio letter The portfolio began investing on 10 November and holds twelve companies whose reported growth is accelerating or compounding. Each purchase this week followed a dated company report. https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-12-CHYM-buy Thu, 12 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:buy ticker:CHYM Bought CHYM on results. The fact behind it, dated 4 November 2026: Q3 2026 results: revenue rose 32% to $718.0 million (27% in Q2), adjusted EBITDA was $137.3 million at a 19% margin, and full-year guidance was raised a third time to $2.792–2.802 billion of revenue and $519–524 million of adjusted EBITDA. https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-12-ETON-buy Thu, 12 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:buy ticker:ETON Bought ETON on results. The fact behind it, dated 5 November 2026: Q3 2026 results: revenue rose 158% to $57.9 million, adjusted EBITDA was $28.5 million (49% of revenue), and 2026 revenue guidance was raised to more than $175 million from more than $145 million. https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-12-QNST-buy Thu, 12 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:buy ticker:QNST Bought QNST on results. The fact behind it, dated 4 November 2026: Fiscal Q1 2027 results: revenue rose 46% to $416.7 million against a $370–380 million guide, adjusted EBITDA rose 108% to $42.7 million, and fiscal 2027 guidance was raised to $1.5–1.6 billion of revenue and $155–165 million of adjusted EBITDA. https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-12-XERS-buy Thu, 12 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:buy ticker:XERS Bought XERS on results. The fact behind it, dated 5 November 2026: Q3 2026 results: total revenue rose 44% to $107.2 million, Recorlev rose 93% to $71.5 million, 2026 revenue guidance was raised to $395–405 million from $385–390 million and the 2030 revenue outlook to more than $1 billion from about $750 million. https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-11-PLMR-buy Wed, 11 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:buy ticker:PLMR Bought PLMR on results. The fact behind it, dated 4 November 2026: Q3 2026 results: gross written premium +28.4% to $767.0 million, adjusted net income +47.4% to $81.3 million, and fiscal 2026 adjusted net income guidance raised a fourth time, to $280–285 million from $270–280 million. https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-11-ZETA-buy Wed, 11 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:buy ticker:ZETA Bought ZETA on results. The fact behind it, dated 9 November 2026: Q3 2026 results: revenue +46% to $492.7 million, +30% excluding Marigold and political revenue (28% in Q2), free cash flow +73% to $81.5 million, and full-year revenue guidance raised to $1.853–1.857 billion from $1.811–1.824 billion. https://frontierpicks.com/dossiers/MSFT/ https://frontierpicks.com/dossiers/MSFT/#2026-11-11 Wed, 11 Nov 2026 03:34:00 GMT FrontierPicks conviction:medium portfolio megacap-ai-platforms ai-enterprise-software ai-datacenter-infrastructure Rating cut from High to Medium. Company news, 10 November 2026: Anthropic launched Claude Sheets, a spreadsheet that competes with Excel, alongside Claude Data and Claude Whiteboards; Microsoft shares fell as much as 3% intraday and closed down 2.2% at $533.16. Microsoft's shares are modestly more likely to lead the S&P 500 over three months because Azure grew 48% in the September quarter and is guided to 49–50% for December. The fiscal second-quarter report, expected in late January 2027, shows whether Azure delivers despite Anthropic's Excel rival and the 12–14 November outage. This names Anthropic, the company that makes Claude, the AI model that wrote it. The conflict of interest, stated: https://frontierpicks.com/trust/#conflict-of-interest https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-10-APPN-buy Tue, 10 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:buy ticker:APPN Bought APPN in the portfolio's opening purchases. The fact behind it, dated 5 November 2026: Q3 2026 results: revenue +25% to $234.6 million, cloud net annual recurring revenue expansion 120%, Q4 cloud guided to +22–24%. https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-10-KNSA-buy Tue, 10 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:buy ticker:KNSA Bought KNSA in the portfolio's opening purchases. The fact behind it, dated 27 October 2026: Q3 2026 results: ARCALYST net revenue $286.0 million (+58%), 2026 guide raised a third time to $1.045–1.050 billion. https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-10-LLY-buy Tue, 10 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:buy ticker:LLY Bought LLY in the portfolio's opening purchases. The fact behind it, dated 29 October 2026: Q3 2026 results: revenue +39% to $24.4 billion, volume +53%, 2026 guide raised to $91–92 billion from $85–87 billion. https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-10-MSFT-buy Tue, 10 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:buy ticker:MSFT Bought MSFT in the portfolio's opening purchases. The fact behind it, dated 28 October 2026: Fiscal 2027 Q1 results: revenue +19%, Azure +48% constant currency, Q2 Azure guided to 49–50%. https://frontierpicks.com/portfolio/#changes https://frontierpicks.com/portfolio/#2026-11-10-U-buy Tue, 10 Nov 2026 21:45:00 GMT FrontierPicks portfolio portfolio:buy ticker:U Bought U in the portfolio's opening purchases. The fact behind it, dated 5 November 2026: Q3 2026 results: Strategic Grow $431.5 million (+90%), Vector +40% quarter over quarter, first GAAP profit.